Tvorogova M G, Titov V N, Sanfirova V M
Farmakol Toksikol. 1982 Jul-Aug;45(4):48-51.
The effect of cholestyramine on lipoprotein metabolism in the rat blood has been explored. Administration of cholestyramine changed both the concentration and the ratio of lipid components in all the classes of lipoproteins. Despite the fact that the activity of postheparin lipoprotein lipase was unchanged upon cholestyramine action, almost double rise in the activity of LChAT and an increase in the specific radioactivity of LDL attests to the intensification of VLDL metabolism. Therefore, the increased biosynthesis of VLDL by the liver is the main reason for the development of hypertriglyceridemia upon the action of cholestyramine.
已对消胆胺对大鼠血液中脂蛋白代谢的影响进行了研究。给予消胆胺改变了所有脂蛋白类中脂质成分的浓度和比例。尽管在消胆胺作用下肝素后脂蛋白脂肪酶的活性未发生变化,但卵磷脂胆固醇酰基转移酶(LChAT)活性几乎翻倍升高以及低密度脂蛋白(LDL)比放射性增加证明极低密度脂蛋白(VLDL)代谢增强。因此,肝脏中VLDL生物合成增加是消胆胺作用下高甘油三酯血症发生的主要原因。